Nissay Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.91M | Buy |
10,890
+132
| +1% | +$35.7K | 0.02% | 423 |
|
|
2025
Q4 | $2.7M | Buy |
10,758
+55
| +0.5% | +$14.6K | 0.01% | 440 |
|
|
2025
Q3 | $3.07M | Buy |
10,703
+94
| +0.9% | +$25.2K | 0.02% | 409 |
|
|
2025
Q2 | $2.78M | Buy |
10,609
+243
| +2% | +$59.2K | 0.02% | 440 |
|
|
2025
Q1 | $2.41M | Buy |
10,366
+78
| +0.8% | +$18.9K | 0.02% | 461 |
|
|
2024
Q4 | $2.37M | Sell |
10,288
-27
| -0.3% | -$6.19K | 0.01% | 473 |
|
|
2024
Q3 | $2.31M | Buy |
10,315
+324
| +3% | +$71.2K | 0.01% | 490 |
|
|
2024
Q2 | $2.03M | Buy |
9,991
+238
| +2% | +$48.4K | 0.01% | 492 |
|
|
2024
Q1 | $2.13M | Sell |
9,753
-209
| -2% | -$46K | 0.01% | 486 |
|
|
2023
Q4 | $2.26M | Buy |
9,962
+392
| +4% | +$82.3K | 0.02% | 431 |
|
|
2023
Q3 | $1.92M | Sell |
9,570
-1,188
| -11% | -$251K | 0.02% | 441 |
|
|
2023
Q2 | $2.23M | Sell |
10,758
-137
| -1% | -$26.6K | 0.02% | 416 |
|
|
2023
Q1 | $2.15M | Sell |
10,895
-575
| -5% | -$118K | 0.02% | 418 |
|
|
2022
Q4 | $2.32M | Sell |
11,470
-556
| -5% | -$109K | 0.02% | 397 |
|
|
2022
Q3 | $2.12M | Buy |
12,026
+373
| +3% | +$76.4K | 0.02% | 405 |
|
|
2022
Q2 | $2.35M | Sell |
11,653
-237
| -2% | -$50.5K | 0.02% | 371 |
|
|
2022
Q1 | $2.69M | Buy |
11,890
+210
| +2% | +$49.4K | 0.02% | 390 |
|
|
2021
Q4 | $3.15M | Buy |
11,680
+163
| +1% | +$40.4K | 0.02% | 368 |
|
|
2021
Q3 | $2.79M | Buy |
11,517
+462
| +4% | +$116K | 0.02% | 375 |
|
|
2021
Q2 | $2.62M | Sell |
11,055
-179
| -2% | -$40.8K | 0.02% | 377 |
|
|
2021
Q1 | $2.46M | Sell |
11,234
-273
| -2% | -$54.8K | 0.02% | 372 |
|
|
2020
Q4 | $2.01M | Sell |
11,507
-63
| -0.5% | -$10.9K | 0.03% | 396 |
|
|
2020
Q3 | $1.87M | Buy |
11,570
+235
| +2% | +$37.2K | 0.03% | 372 |
|
|
2020
Q2 | $1.62M | Buy |
11,335
+783
| +7% | +$108K | 0.03% | 415 |
|
|
2020
Q1 | $1.15M | Buy |
10,552
+252
| +2% | +$36.3K | 0.03% | 414 |
|
|
2019
Q4 | $1.5M | Sell |
10,300
-93
| -0.9% | -$13.4K | 0.03% | 426 |
|
|
2019
Q3 | $1.5M | Buy |
10,393
+457
| +5% | +$66.7K | 0.04% | 414 |
|
|
2019
Q2 | $1.48M | Sell |
9,936
-651
| -6% | -$90.8K | 0.04% | 411 |
|
|
2019
Q1 | $1.39M | Buy |
10,587
+394
| +4% | +$48.5K | 0.04% | 408 |
|
|
2018
Q4 | $1.11M | Sell |
10,193
-328
| -3% | -$43.9K | 0.03% | 410 |
|
|
2018
Q3 | $1.57M | Buy |
10,521
+314
| +3% | +$47.8K | 0.04% | 368 |
|
|
2018
Q2 | $1.57M | Buy |
10,207
+684
| +7% | +$103K | 0.05% | 360 |
|
|
2018
Q1 | $1.32M | Buy |
9,523
+181
| +2% | +$26.6K | 0.04% | 363 |
|
|
2017
Q4 | $1.28M | Buy |
+9,342
| New | +$1.23M | 0.04% | 375 |
|
Other funds holding LH
VCM
VPM
Nissay Asset Management's LH Position: Q1 2026 in Review
Nissay Asset Management increased its Labcorp (LH) stake by 1.2% in Q1 2026, buying an estimated $35.7K and bringing the position to 10,890 shares worth $2.91M. The position accounts for 0.02% of the portfolio, ranked #423.
Nissay Asset Management first reported a position in LH in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.15M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Nissay Asset Management held 10,890 shares of Labcorp worth $2.91M as of Q1 2026.
- Nissay Asset Management bought 132 Labcorp shares in Q1 2026, an estimated $35.7K.
- Labcorp made up 0.02% of Nissay Asset Management's portfolio in Q1 2026, its #423 holding.
- Nissay Asset Management first reported a position in Labcorp in Q4 2017 and has held it in 34 quarters since.
- Nissay Asset Management's Labcorp position peaked at $3.15M in Q4 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.